Sine die came for Oregon’s 2026 legislative session last Friday, March 6th. I previewed the roster of cannabis bills in play back on February 12th. Two of them passed; two of them failed. Below is a recap of the action, with links to each bill in the headers. HB 4139 (FAILED) This was the session’s […]
Most commentary on the “hemp ban” included in the November funding bill has focused on two related questions: (1) which products and activities may become unlawful on November 12, 2026; and (2) whether Congress will materially amend or delay the ban before then. I recently discussed another consequence operators should be considering as the deadline […]
In the last year or two, we have seen a growing number of marijuana businesses take the position that IRC 280E no longer applies to them. Some of these businesses have taken that position in consultation with lawyers and CPAs. This shift in strategy predates Trump’s Executive Order of December 18, 2025, to reschedule marijuana […]
Oregon’s 2026 legislative session began last week on February 2. The biennial “short session” will last but 35 days, and focus on budget shortfalls, transportation and housing—which is to say that cannabis is not a priority. That said, of the 300 or so introduced bills, there are four cannabis-related submissions. That’s where I come in. […]
Earlier this month, the Bailiwick of Jersey appeared poised to take a measured, evidence-based step toward re-examining its approach to non-medical cannabis. Three reform proposals put forward by Tom Binet, Minister for Health and Social Services, were expected to be debated by the States Assembly of Jersey on February 3, 2026. That debate has now […]
Last month, we hosted a webinar on federal cannabis law and policy in 2026. While things are not where we’d like them to be, it’s amazing to consider everything that has happened over the years. From a lawyering perspective, it’s almost unbelievable. I have worked as a business lawyer in the cannabis industry for over […]
Most commentary on the “hemp ban” included in the November funding bill has focused on two, related considerations: (1) which products and activities will become unlawful on November 12, 2026, and (2) whether Congress will materially amend, or delay, the ban before then. While that focus is understandable, it overlooks a critical, and more immediate, […]
U.S. federal cannabis law is at a pivotal moment heading into 2026. In a January 15th webinar, attorneys Jason Adelstone and Vince Sliwoski examined two major federal developments that are poised to reshape the industry: the Executive Order directing the rescheduling of marijuana under the Controlled Substances Act, and new Congressional legislation redefining “hemp,” effective […]
Harris Sliwoski attorney Jason Adelstone will be participating in CannaGen Sesh 3: Deeply Seeded, a webinar hosted by CannaGen on Thursday, January 22, from 11:00–12:00 PM PST. This session will focus on a significant but underappreciated change in federal hemp law that will materially affect cannabis genetics, seed commerce, and cross-border operations. Under recent amendments […]
It’s MLK Day once again. I have written an MLK Day post on this blog for nine consecutive years. The theme of all these posts is that cannabis is a civil rights issue, and that Dr. King would have advocated for ending marijuana prohibition based on that fact. Each year, I have demonstrated with facts […]
As extraction technologies improve and stabilization techniques advance, acidic cannabinoids may represent one of the most promising frontiers in cannabis product innovation. The post Are Acidic Cannabinoids the Next Frontier for Product Innovation? appeared first on Cannabis Industry Journal.
A Look at the Bloomwell Group's German Business Model The post The Case For Cannabis Telemedicine: Can it Work in the US? appeared first on Cannabis Industry Journal.
Cannabis medicine is about to move beyond today’s trial-and-error approach toward more personalized, precise treatments The post The Power of AI and How it Will Transform Cannabis Medicine appeared first on Cannabis Industry Journal.
Consumers are demanding clean, quality cannabis—and without a cold chain, the industry risks turning craft flower into commodity biomass. The post Preservation is the Buzzword for 2026 appeared first on Cannabis Industry Journal.
Sensory science, blending expertise, disciplined quality control, and cultural storytelling define a luxury brand. The post What Cannabis Can Learn from the Luxury Perfume World appeared first on Cannabis Industry Journal.
Custom Cones shines a light on a lurking opportunity; While joints may be the top way people consume, 33% of smokers say their favorite way to consume are with blunts. The post How To Use Blunts As a Brand Building Catalyst appeared first on Cannabis Industry Journal.
Strategy, Scale, and Survival in a Maturing Adult-Use Market The post Building Inside Maryland’s Limited License Cannabis Market appeared first on Cannabis Industry Journal.
In an industry defined by local operators struggling to stay afloat and confined within their borders, Michael Sassano, founder and CEO of Somai Pharmaceuticals, has created a blueprint for scaling cannabis worldwide with pharmaceutical discipline and regulatory agility. With headquarters in Lisbon and operations in 12 countries today, Somai is preparing to reach 18… […]
Discussions on the overlooked potential of these powerful compounds are on the rise The post NIH Releases Scientific Paper on the Therapeutic Value of Acidic Cannabinoids appeared first on Cannabis Industry Journal.
We help YOU put together the business plan that’s right for YOU. Then we help YOU make it a reality with the right facility, the right equipment and supplies, the right staff, the right training, and the right marketing plan.